Quantessence Capital’s Carter's CRI Stock Holding History

Quantessence Capital’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-30,243	Closed	-$1.24M	–	244
2025 Q1	$1.24M	Buy	+30,243	New	+$1.45M	0.31%	72

Other funds holding CRI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RWWM Inc Rocklin, California $1.37B AUM 3.81% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Quantessence Capital's CRI Position: Q2 2025 in Review

Quantessence Capital sold out of Carter's (CRI) in Q2 2025, closing a stake of 30,243 shares — an estimated $1.24M sold.

Quantessence Capital first reported a position in CRI in Q1 2025 and held it in 1 quarter. The position peaked at $1.24M in Q1 2025. 268 funds tracked by Wall St. Rank hold CRI as of Q2 2025.

Quantessence Capital reported no remaining Carter's position as of Q2 2025 after selling out during the quarter.
Quantessence Capital sold 30,243 Carter's shares in Q2 2025, an estimated $1.24M.
Quantessence Capital first reported a position in Carter's in Q1 2025 and held it in 1 quarter.
Quantessence Capital's Carter's position peaked at $1.24M in Q1 2025.
268 funds tracked by Wall St. Rank held Carter's as of Q2 2025.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.